Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?-Reference-Cited by-同舟云学术

Comparative pharmacogenetic analysis of risk polymorphisms in Caucasian and Vietnamese children with acute lymphoblastic leukemia: prediction of therapeutic outcome?

Published:2015-02-20 Issue:3 Volume:79 Page:429-440
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Vu Hoang Phuong Thu¹²³⁴,Ambroise Jérôme¹,Dekairelle Anne-France¹,Durant Jean-François¹,Butoescu Valentina⁵,Dang Chi Vu Luan³⁴,Huynh Nghia⁴,Nguyen Tan Binh³,Robert Annie⁶,Vermylen Christiane²,Gala Jean-Luc¹⁷

Affiliation:

1. Centre de Technologies Moléculaires Appliquées (CTMA); Institut de Recherche Expérimentale et Clinique (IREC); Université catholique de Louvain (UCL); Brussels Belgium

2. Service d'hématologie et oncologie pédiatrique; Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCL); Brussels Belgium

3. Pham Ngoc Thach University of Medecin; Ho Chi Minh city Vietnam

4. Blood Transfusion and Hematology Hospital; Ho Chi Minh city Vietnam

5. Service d'Urologie; Institut de Recherche Expérimentale et Clinique (IREC); Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCL); Brussels Belgium

6. Pôle d'épidémiologie et Biostatistique; Institut de Recherche Expérimentale et Clinique (IREC); Université catholique de Louvain (UCL); Brussels Belgium

7. Defence Laboratories Department; Belgian Armed Forces; Brussels Belgium

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12481/fullpdf

Reference67 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy;Cheok;Nat Rev Cancer,2006

3. Pharmacogenomics of acute lymphoblastic leukemia;Kager;Curr Opin Hematol,2006

4. Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia;Adam de Beaumais;Eur J Clin Pharmacol,2012

5. Moving towards individualized medicine with pharmacogenomics;Evans;Nature,2004

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of race/ethnicity with innate immune tumor microenvironment of children with B-acute lymphoblastic leukemia;Journal for ImmunoTherapy of Cancer;2022-06

2. Susceptibility to thiopurine toxicity by TPMT and NUDT15 variants in Colombian children with acute lymphoblastic leukemia;Colombia Medica;2021-12-24

3. Susceptibility to thiopurine toxicity by TPMT and NUDT15 variants in Colombian children with acute lymphoblastic leukemia;COLOMB MEDICA;2021

4. Clinical Implications of Methotrexate Pharmacogenetics in Childhood Acute Lymphoblastic Leukaemia;Current Drug Metabolism;2019-06-11

5. MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy;Pharmacogenomics and Personalized Medicine;2017-03